0

Your Cart is Empty

5-HTP

5-HTP is a natural amino acid extracted from the Griffonia simplicifolia plant. The natural AMORYN formula combines 5-HTP with other clinically-researched ingredients to improve mood and relieve feelings of sadness and worry. Continue reading to learn more about 5-HTP and to find out more about how AMORYN can help you maintain emotional health.

Your body converts 5-HTP into serotonin, a neurotransmitter that regulates mood, anxiety, sleep and aggression. Medical researchers believe that adequate levels of serotonin are necessary for maintaining emotional wellness. By providing the body with the raw materials necessary to produce serotonin, the 5-HTP in AMORYN may effectively increase the level of serotonin in the brain.3

Supplementing your normal diet with 5-HTP may be an effective way to boost mood and promote a positive outlook. 3,4 In fact, the March 2005 issue of Alternative Medicinemagazine recommended 5-HTP as the most important amino acid for improving emotional health. 1,2 (The article also listed B6, B12 and Folic Acid - the three B vitamins in AMORYN - as the best vitamins for improving mood.)


Order AMORYN now
 and boost your serotonin, and your mood, with 5-HTP.5-HTP is considered safe when taken as directed. Two capsules of AMORYN contain 50 mg of 5HTP, an amount carefully selected to gently increase serotonin levels. This mild dose synergizes with AMORYN's main ingredient, high-potency St. John's Wort extract. While many natural supplements combine St. John's Wort (SJW) with 5-HTP, AMORYN delivers SJW extract standardized to contain at least 3% hyperforin (over 18mg), the potency shown to effectively improve mood in extensive clinical research.

Return to AMORYN ingredients.

(1) Evans, K. (2005 March). Alternative Medicine Magazine. 
(2) Des Jarlais, G. (2005 March). Alternative Medicine Magazine. 
(3) Birdsall, TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative Medicine Review 1998 Aug;3(4):271-80. 
(4) Meyers, S. (2000 Feb). Alternative Medicine Review. 

Newsletter